PRF1 and cancer: Conversely, NK cells release EVs that contain functional molecules like NKG2D/CD94, perforin, and granzymes, contributing to NK cell cytotoxicity and presenting a potential therapeutic approach to enhance NK cell anti-cancer actions 128 (Figure 3b).